News stories about Cardinal Health (NYSE:CAH) have trended somewhat positive on Thursday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.4604037318851 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

A number of research firms recently commented on CAH. ValuEngine lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research report on Monday, January 29th. Mizuho set a $73.00 price target on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Robert W. Baird reaffirmed a “hold” rating and set a $80.00 price target on shares of Cardinal Health in a research report on Wednesday, January 17th. Finally, Evercore ISI began coverage on shares of Cardinal Health in a research report on Thursday, January 4th. They set an “in-line” rating and a $67.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $74.61.

Cardinal Health (NYSE:CAH) opened at $65.14 on Thursday. The company has a quick ratio of 0.52, a current ratio of 1.06 and a debt-to-equity ratio of 1.35. Cardinal Health has a 1-year low of $54.66 and a 1-year high of $84.88. The company has a market cap of $20,490.00, a PE ratio of 18.99, a price-to-earnings-growth ratio of 1.46 and a beta of 0.95.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The firm had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. During the same period last year, the firm earned $1.24 EPS. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. equities research analysts predict that Cardinal Health will post 5.17 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Sunday, April 15th. Shareholders of record on Monday, April 2nd will be issued a $0.4624 dividend. This represents a $1.85 annualized dividend and a yield of 2.84%. Cardinal Health’s dividend payout ratio is currently 53.94%.

In other Cardinal Health news, CEO Michael C. Kaufmann sold 18,586 shares of the firm’s stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $73.90, for a total value of $1,373,505.40. Following the transaction, the chief executive officer now directly owns 211,849 shares of the company’s stock, valued at approximately $15,655,641.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.97% of the stock is owned by company insiders.

WARNING: This piece of content was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Insider Buying and Selling by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with's FREE daily email newsletter.